Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 1631 entries
View as:

Phase Ib Study of Anetumab Ravtansine in Combination With Pegylated Liposomal Doxorubicin in Patients With Recurrent Mesothelin-expressing Platinum-resistant Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02751918 Org: User:
Start: 06/08/16 End: 10/31/19 Due: 10/31/20

Evaluation of the Safety and Efficacy of Vardenafil in Subjects With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00681772 Org: User:
Start: 03/31/03 End: 11/30/03 Due: 11/30/04

Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women

Phase: N/A Priority: Normal
NCT ID: NCT02434640 Org: User:
Start: 04/30/15 End: 04/30/16 Due: 04/30/17

Efficacy of Ventavis Used in Real-life Setting.

Phase: N/A Priority: Normal
NCT ID: NCT01355380 Org: User:
Start: 08/05/10 End: 09/22/16 Due: 09/22/17

Study to Test the Safety of an Investigational Drug Given Repeatedly to Adult Men With Severe Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT03996486 Org: User:
Start: 10/28/19 End: 07/31/20 Due: 07/31/21

A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM)

Phase: N/A Priority: Normal
NCT ID: NCT05004428 Org: User:
Start: 08/14/21 End: 02/11/22 Due: 02/11/23

A Study to Learn How the Study Treatment BAY1753011 Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body When Given Once as Tablet in Male and Female Participants With Reduced Kidney Function Compared to Matched Participants With Normal Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05599997 Org: User:
Start: 11/25/19 End: 05/18/21 Due: 05/18/22

Comparative Trial in Hormone Withdrawal Associated Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT01076582 Org: User:
Start: 04/30/10 End: 10/31/11 Due: 10/31/12

A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06764316 Org: User:
Start: 02/28/25 End: 12/31/33 Due: 12/31/34

Factor XI LICA to Reduce Events Such as Heart Attack and Stroke in Patients Whose Kidneys Are no Longer Able to Work as They Should and Require Treatment to Filter Wastes From the Blood: Focus is on the Safety of BAY2976217 and the Way the Body Absorbs, Distributes and Removes the Study Drug

Phase: N/A Priority: Normal
NCT ID: NCT04534114 Org: User:
Start: 09/04/20 End: 05/12/22 Due: 05/12/23

A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer or Other Select Solid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT06345001 Org: User:
Start: 08/26/24 End: 03/31/25 Due: 03/31/26

Survey on Patient Satisfaction Rate for Mirena Use in Heavy Menstrual Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00874653 Org: User:
Start: 04/30/08 End: 12/31/08 Due: 12/31/09

A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses

Phase: N/A Priority: Normal
NCT ID: NCT05491642 Org: User:
Start: 09/08/22 End: 04/28/23 Due: 04/28/24

Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being

Phase: N/A Priority: Normal
NCT ID: NCT00988910 Org: User:
Start: 01/31/08 End: 12/31/10 Due: 12/31/11

Study of Rogaratinib (BAY1163877) vs Chemotherapy in Patients With FGFR (Fibroblast Growth Factor Receptor)-Positive Locally Advanced or Metastatic Urothelial Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03410693 Org: User:
Start: 05/31/18 End: 10/27/20 Due: 10/27/21

Avelox for Treatment of Elderly Patients With Community Acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT00665327 Org: User:
Start: 11/30/02 End: 04/30/04 Due: 04/30/05

18794 - Human Photo Toxicity Test

Phase: N/A Priority: Normal
NCT ID: NCT02751372 Org: User:
Start: 05/02/16 End: 05/06/16 Due: 05/06/17

A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best

Phase: N/A Priority: Normal
NCT ID: NCT03373422 Org: User:
Start: 11/30/17 End: 10/22/18 Due: 10/22/19

BAY58-2667 Dose Finding Trial Investigating Fixed Doses in Patients With Acute Decompensated Chronic Congestive Heart Failure (ADHF)

Phase: N/A Priority: Normal
NCT ID: NCT01065077 Org: User:
Start: 03/31/10 End: 02/28/11 Due: 02/28/12

High Dose BAYA1040_Nifedipine: a Dose-comparative Study

Phase: N/A Priority: Normal
NCT ID: NCT01287260 Org: User:
Start: 01/31/11 End: 08/31/11 Due: 08/31/12

BAY 0 9867 Cipro Pediatric Use Study (QUIP)

Phase: N/A Priority: Normal
NCT ID: NCT00761462 Org: User:
Start: 10/31/99 End: 01/31/08 Due: 01/31/09

A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Phase: N/A Priority: Normal
NCT ID: NCT05643573 Org: User:
Start: 12/05/22 End: 01/31/24 Due: 01/31/25

Comparative Safety Study of New Sinecort Formulation Versus Positive Control

Phase: N/A Priority: Normal
NCT ID: NCT00885937 Org: User:
Start: 04/30/09 End: 05/31/09 Due: 05/31/10

Sun Protection Factor Assay (SPF Assay 105/2016)

Phase: N/A Priority: Normal
NCT ID: NCT02891044 Org: User:
Start: 08/15/16 End: 09/08/16 Due: 09/08/17

Atrial Fibrillation Screening With a Smartphone Device and iECG Application

Phase: N/A Priority: Normal
NCT ID: NCT02534532 Org: User:
Start: 10/31/15 End: 04/30/16 Due: 04/30/17